Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy (Oncogene, 2018)

(untitled) - Zhu, B; Tang, L; Chen, S; Yin, C; Peng, S; Li, X; Liu, T; Liu, W; Han, C; Stawski, L; Xu, Z; Zhou, G; et al.